帽辅助前视内镜与侧视十二指肠镜在Billroth II胃切除术后ERCP中的系统评价与荟萃分析
该系统评价与荟萃分析比较了帽辅助前视内镜与侧视十二指肠镜在Billroth II胃切除术后患者ERCP中的疗效与安全性,纳入7项观察性研究(约350例患者、727例操作)。两组胆管插管成功率和临床成功率无显著差异,总体不良事件率相当;帽辅助前视内镜组术后胰腺炎有非显著数值升高,穿孔率低且无显著差异。证据尚不能确定两种方法等效或优劣。
要点
- 帽辅助前视内镜与侧视十二指肠镜在Billroth II术后ERCP的胆管插管和临床成功率无显著差异。
- 穿孔率低且两组无显著差异,证据尚不足以判定两种方法等效或优劣。
核心结论
- 帽辅助前视内镜与侧视十二指肠镜在Billroth II胃切除术后ERCP中显示出相似的疗效。
- 主要不良事件虽无统计学显著差异,但有限统计效能可能掩盖临床相关差异,需谨慎解读。
- 当前证据不支持对任一方法的等效性或优越性做出确定结论,需更大样本比较研究。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Embase、Scopus和Cochrane Library从建库至2025年10月。
- 纳入比较帽辅助前视内镜与侧视十二指肠镜在成人Billroth II胃切除术后ERCP的观察性研究。
- 共纳入7项观察性研究,约350例患者和727例操作;采用随机效应模型计算汇总风险比(RR)及95%CI,用I2统计量评估异质性。
主要发现
- 胆管插管成功率和临床成功率在两种方法间无统计学显著差异。
- 总体不良事件率两组相当。
- 患者层面与操作层面分析结果一致。
临床怎么用
- 在Billroth II胃切除术后患者行ERCP时,帽辅助前视内镜与侧视十二指肠镜均可作为选择,两者疗效相似。
- 选择帽辅助前视内镜时需关注术后胰腺炎的潜在数值升高趋势,尽管未达统计学显著。
- 因证据有限,临床决策应个体化,并考虑操作者经验与患者具体情况。
局限性
- 仅纳入观察性研究,可能存在选择偏倚和混杂因素。
- 样本量有限(约350例患者、727例操作),统计效能不足,可能掩盖临床相关差异。
- 术后胰腺炎和穿孔等不良事件的分析基于少量事件,结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: ERCP in patients with Billroth II gastrectomy remains technically challenging. Although both the conventional side-viewing duodenoscope and the forward-viewing endoscope with a distal cap are used in this setting, comparative evidence specifically assessing the role of the distal cap is limited. This study represents the first systematic review and meta-analysis comparing the efficacy and safety of cap-assisted forward-viewing endoscopy versus side-viewing duodenoscopy for ERCP in patients with Billroth II anatomy. METHODS: A comprehensive literature search was conducted in PubMed, Embase, Scopus, and the Cochrane Library from inception through October 2025. Comparative observational studies evaluating ERCP performed with a cap-assisted forward-viewing endoscope versus a side-viewing duodenoscope in adult patients with prior Billroth II gastrectomy were included, with a focus on efficacy and safety outcomes. Pooled risk ratios (RRs) with 95% CIs were calculated using random-effects models, and heterogeneity was assessed using the I2 statistic. Analyses were performed on both a per-patient and per-procedure basis. RESULTS: Seven observational studies, comprising approximately 350 patients and 727 procedures, were included. No statistically significant differences were observed between the 2 approaches in terms of biliary cannulation success and clinical success. Overall adverse event rates were comparable between groups. Post-ERCP pancreatitis showed a nonsignificant numerical increase with cap-assisted forward-viewing endoscopy in both the procedure-level analysis (14.5% vs 6.7%; RR, 2.11; 95% CI, 0.90-4.92; P = .08; I2 = 0%) and the patient-level analysis (10.2% vs 4.5%; RR, 2.23; 95% CI, 0.66-7.54; P = .20; I2 = 0%). Conversely, perforation rates were low and did not differ significantly, with a nonsignificant numerical reduction favoring cap-assisted forward-viewing endoscopy in procedure-level (1.1% vs 1.2%; RR, 0.70; 95% CI, 0.11-4.34; P = .70; I2 = 0%) and patient-level analyses (1.7% vs 0.9%; RR, 0.88; 95% CI, 0.09-8.30; P = .91; I2 = 0%). Findings were consistent across per-patient and per-procedure analyses. CONCLUSIONS: Cap-assisted forward-viewing endoscopy and side-viewing duodenoscopy showed similar efficacy for ERCP in patients with Billroth II gastrectomy. Although no statistically significant differences were observed in major adverse events, these findings should be interpreted with caution because limited statistical power may have obscured clinically relevant differences. Current evidence does not support a firm conclusion regarding equivalence or superiority of either approach, and larger comparative studies are needed to better define their relative efficacy and safety.
引用
- Guriam G, Pornchai A, Pires Dutra L, et al. Forward-viewing endoscopy with cap-fitting versus side-viewing duodenoscope for endoscopic retrograde cholangiopancreatography in Billroth II gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc. 2026. PMID: 42250770. doi:10.1016/j.gie.2026.05.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。